RECRUITING

Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This pilot study will investigate the clinical and neurophysiological effects of repetitive transcranial magnetic stimulation (rTMS) followed by comprehensive behavioral intervention for tics (CBIT) in adult patients with Tourette's Syndrome (TS). Two groups of moderate disease severity will be randomized to receive active or sham rTMS targeted to the supplementary motor area (SMA) followed by eight CBIT sessions. The change in tic frequency and severity (primary outcome) and neurophysiological changes (secondary outcome) will be compared between the two groups. The central hypothesis is that low frequency rTMS will augment the effects of CBIT through favorable priming of the SMA network.

Official Title

Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study

Quick Facts

Study Start:2024-03-12
Study Completion:2025-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05705999

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older
  2. * Diagnosis of Tourette Syndrome
  3. * Moderate Tic Severity at baseline
  1. * Presence of metallic objects or neurostimulators in the brain
  2. * Pregnancy
  3. * History of active seizures or epilepsy
  4. * Contraindications to receiving fMRI
  5. * Inability to participate in CBIT due to other underlying cognitive or medical condition

Contacts and Locations

Study Contact

Jessica Frey, MD
CONTACT
304-598-6127
Jessica.frey@hsc.wvu.edu

Principal Investigator

Jessica Frey, MD
PRINCIPAL_INVESTIGATOR
WVU RNI

Study Locations (Sites)

WVU RNI
Morgantown, West Virginia, 26506
United States

Collaborators and Investigators

Sponsor: West Virginia University

  • Jessica Frey, MD, PRINCIPAL_INVESTIGATOR, WVU RNI

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-12
Study Completion Date2025-12-30

Study Record Updates

Study Start Date2024-03-12
Study Completion Date2025-12-30

Terms related to this study

Keywords Provided by Researchers

  • Tourette Syndrome
  • Comprehensive Behavioral Intervention for Tics
  • Transcranial Magnetic Stimulation

Additional Relevant MeSH Terms

  • Tourette Syndrome